• For Researchers

The (un)usual suspects – how early detection research embraces interdisciplinary science

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

20 August 2021

• Health & Medicine
• Science & Technology

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours. The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

13 August 2021

• For Researchers

On your marks, get set… start-up!

Explore three of the latest companies to come out of one of our entrepreneurial programmes. Explore three of the latest companies to come out of one of our entrepreneurial programmes.

13 August 2021

• Science & Technology
• For Researchers
• Health & Medicine

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

10 August 2021

• For Researchers

The right combination for early detection

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field

4 August 2021

• For Researchers
• Science & Technology

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

28 July 2021

• Science & Technology

Scientists developing urine and blood tests to detect brain tumours

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

23 July 2021

• For Researchers

A vision for the next decade of UK life sciences

What could the government’s Life Sciences Vision mean for cancer research? What could the government’s Life Sciences Vision mean for cancer research?

21 July 2021

• For Researchers

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

2 July 2021

• Science & Technology

Genetic discovery could guide treatment for aggressive childhood cancer

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

28 June 2021

• Health & Medicine
• Science & Technology

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back. Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back.

23 June 2021

• Health & Medicine

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.   Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

18 June 2021